Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal


Suchbegriffe: NEOPLASM RECURRENCE, LOCAL - , . Treffer: 84


Schutgens, EM; Picci, P; Baumhoer, D; Pollock, R; Bovée, JVMG; Hogendoorn, PCW; Dijkstra, PDS; Rueten-Budde, AJ; Jutte, PC; Traub, F; Leithner, A; Tunn, PU; Funovics, P; Sys, G; San-Julian, M; Schaap, GR; Dürr, HR; Hardes, J; Healey, J; Capanna, R; Biau, D; Gomez-Brouchet, A; Wunder, J; Cosker, TDA; Laitinen, MK; Niu, X; Kostiuk, V; van de Sande, MAJ; Adamantinoma Research Group Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases.
J Bone Joint Surg Am. 2020; 102(19):1703-1713 Doi: 10.2106/JBJS.19.01056 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



Neuwirth, M; Kalt, L; Pipam, W; Rab, M [Long-term experience with Collagenase Clostridium Histolyticum (CCH, Xiapex®) for the treatment of Dupuytren's contracture: lessons learned].
HANDCHIR MIKROCHIR P. 2019; 51(1): 38-44. Doi: 10.1055/a-0832-2254
Web of Science PubMed FullText FullText_MUG



Margonis, GA; Buettner, S; Andreatos, N; Wagner, D; Sasaki, K; Galjart, B; Kamphues, C; Pawlik, TM; Poultsides, G; Kaczirek, K; Lønning, PE; Verhoef, C; Kreis, ME; Wolfgang, CL; Weiss, MJ The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
J Surg Oncol. 2018; 118(7):1074-1080 Doi: 10.1002/jso.25251
Web of Science PubMed FullText FullText_MUG



Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691 Doi: 10.21873/anticanres.11617 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Lindenmann, J; Fink-Neuboeck, N; Avian, A; Pichler, M; Habitzruther, M; Maier, A; Smolle-Juettner, FM Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Eur J Surg Oncol. 2017; 43(2):445-453 Doi: 10.1016/j.ejso.2016.10.015
Web of Science PubMed FullText FullText_MUG


Posch, F; Leitner, L; Bergovec, M; Bezan, A; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Leithner, A; Szkandera, J Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Clin Orthop Relat Res. 2017; 475(5):1427-1435 Doi: 10.1007/s11999-017-5232-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Riedl, JM; Posch, F; Bezan, A; Szkandera, J; Smolle, MA; Winder, T; Rossmann, CH; Schaberl-Moser, R; Pichler, M; Stotz, M; Stöger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
BMC Cancer. 2017; 17(1):415-415 Doi: 10.1186/s12885-017-3392-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Soukup, V; Čapoun, O; Cohen, D; Hernández, V; Babjuk, M; Burger, M; Compérat, E; Gontero, P; Lam, T; MacLennan, S; Mostafid, AH; Palou, J; van Rhijn, BWG; Rouprêt, M; Shariat, SF; Sylvester, R; Yuan, Y; Zigeuner, R Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
Eur Urol. 2017; 72(5):801-813 Doi: 10.1016/j.eururo.2017.04.015
Web of Science PubMed FullText FullText_MUG


Stacchiotti, S; Gronchi, A; Fossati, P; Akiyama, T; Alapetite, C; Baumann, M; Blay, JY; Bolle, S; Boriani, S; Bruzzi, P; Capanna, R; Caraceni, A; Casadei, R; Colia, V; Debus, J; Delaney, T; Desai, A; Dileo, P; Dijkstra, S; Doglietto, F; Flanagan, A; Froelich, S; Gardner, PA; Gelderblom, H; Gokaslan, ZL; Haas, R; Heery, C; Hindi, N; Hohenberger, P; Hornicek, F; Imai, R; Jeys, L; Jones, RL; Kasper, B; Kawai, A; Krengli, M; Leithner, A; Logowska, I; Martin Broto, J; Mazzatenta, D; Morosi, C; Nicolai, P; Norum, OJ; Patel, S; Penel, N; Picci, P; Pilotti, S; Radaelli, S; Ricchini, F; Rutkowski, P; Scheipl, S; Sen, C; Tamborini, E; Thornton, KA; Timmermann, B; Torri, V; Tunn, PU; Uhl, M; Yamada, Y; Weber, DC; Vanel, D; Varga, PP; Vleggeert-Lankamp, CLA; Casali, PG; Sommer, J Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.
Ann Oncol. 2017; 28(6):1230-1242 Doi: 10.1093/annonc/mdx054 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



Gschwandtner, E; Klatte, T; Swietek, N; Bures, C; Kober, F; Ott, J; Schultheis, A; Neuhold, N; Hermann, M Increase of papillary thyroid microcarcinoma and a plea for restrictive treatment: A retrospective study of 1,391 prospective documented patients.
Surgery. 2016; 159(2): 503-511. Doi: 10.1016/j.surg.2015.06.015
Web of Science PubMed FullText FullText_MUG


Harada, Y; Izumi, H; Noguchi, H; Kuma, A; Kawatsu, Y; Kimura, T; Kitada, S; Uramoto, H; Wang, KY; Sasaguri, Y; Hijioka, H; Miyawaki, A; Oya, R; Nakayama, T; Kohno, K; Yamada, S Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma.
Tumour Biol. 2016; 37(1):1357-1368 Doi: 10.1007/s13277-015-3928-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Stotz, M; Liegl-Atzwanger, B; Posch, F; Mrsic, E; Thalhammer, M; Stojakovic, T; Bezan, A; Pichler, M; Gerger, A; Szkandera, J Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
PLoS One. 2016; 11(7):e0159448-e0159448 Doi: 10.1371/journal.pone.0159448 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


von Bueren, AO; Kortmann, RD; von Hoff, K; Friedrich, C; Mynarek, M; Müller, K; Goschzik, T; Zur Mühlen, A; Gerber, N; Warmuth-Metz, M; Soerensen, N; Deinlein, F; Benesch, M; Zwiener, I; Kwiecien, R; Faldum, A; Bode, U; Fleischhack, G; Hovestadt, V; Kool, M; Jones, D; Northcott, P; Kuehl, J; Pfister, S; Pietsch, T; Rutkowski, S Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
J Clin Oncol. 2016; 34(34):4151-4160 Doi: 10.1200/JCO.2016.67.2428
Web of Science PubMed FullText FullText_MUG


Wolff, I; May, M; Hoschke, B; Zigeuner, R; Cindolo, L; Hutterer, G; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, MD; Salzano, L; Lotrecchiano, G; Shariat, SF; Hohenfellner, M; Waidelich, R; Stief, C; Miller, K; Pahernik, S; Brookman-May, S; Members of the CORONA Project and the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database.
Eur J Surg Oncol. 2016; 42(5):744-750 Doi: 10.1016/j.ejso.2016.01.009
Web of Science PubMed FullText FullText_MUG



Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Ann Oncol. 2015; 26(8):1685-1691 Doi: 10.1093/annonc/mdv215 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Szkandera, J; Herzog, S; Pichler, M; Stiegelbauer, V; Stotz, M; Schaberl-Moser, R; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Renner, W; Lenz, HJ; Berghold, A; Gerger, A LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
Pharmacogenomics J. 2015; 15(5):391-396 Doi: 10.1038/tpj.2015.2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



Blum, A; Hofmann-Wellenhof, R; Marghoob, AA; Argenziano, G; Cabo, H; Carrera, C; Costa Soares de Sá, B; Ehrsam, E; González, R; Malvehy, J; Manganoni, AM; Puig, S; Simionescu, O; Tanaka, M; Thomas, L; Tromme, I; Zalaudek, I; Kittler, H Recurrent melanocytic nevi and melanomas in dermoscopy: results of a multicenter study of the International Dermoscopy Society.
JAMA Dermatol. 2014; 150(2):138-145 Doi: 10.1001/jamadermatol.2013.6908 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Filipits, M; Nielsen, TO; Rudas, M; Greil, R; Stöger, H; Jakesz, R; Bago-Horvath, Z; Dietze, O; Regitnig, P; Gruber-Rossipal, C; Müller-Holzner, E; Singer, CF; Mlineritsch, B; Dubsky, P; Bauernhofer, T; Hubalek, M; Knauer, M; Trapl, H; Fesl, C; Schaper, C; Ferree, S; Liu, S; Cowens, JW; Gnant, M; Austrian Breast and Colorectal Cancer Study Group The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.
Clin Cancer Res. 2014; 20(5):1298-1305 Doi: 10.1158/1078-0432.CCR-13-1845 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Fokas, E; Liersch, T; Fietkau, R; Hohenberger, W; Beissbarth, T; Hess, C; Becker, H; Ghadimi, M; Mrak, K; Merkel, S; Raab, HR; Sauer, R; Wittekind, C; Rödel, C Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.
J Clin Oncol. 2014; 32(15):1554-1562 Doi: 10.1200/JCO.2013.54.3769 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Gerber, NU; von Hoff, K; Resch, A; Ottensmeier, H; Kwiecien, R; Faldum, A; Matuschek, C; Hornung, D; Bremer, M; Benesch, M; Pietsch, T; Warmuth-Metz, M; Kuehl, J; Rutkowski, S; Kortmann, RD Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.
Int J Radiat Oncol Biol Phys. 2014; 89(4):863-871 Doi: 10.1016/j.ijrobp.2014.04.017
Web of Science PubMed FullText FullText_MUG


Mlecnik, B; Bindea, G; Angell, HK; Sasso, MS; Obenauf, AC; Fredriksen, T; Lafontaine, L; Bilocq, AM; Kirilovsky, A; Tosolini, M; Waldner, M; Berger, A; Fridman, WH; Rafii, A; Valge-Archer, V; Pagès, F; Speicher, MR; Galon, J Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients.
Sci Transl Med. 2014; 6(228):228ra37-228ra37 Doi: 10.1126/scitranslmed.3007240 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Ning, Y; Gerger, A; Zhang, W; Hanna, DL; Yang, D; Winder, T; Wakatsuki, T; Labonte, MJ; Stintzing, S; Volz, N; Sunakawa, Y; Stremitzer, S; El-Khoueiry, R; Lenz, HJ Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.
Mol Cancer Ther. 2014; 13(2):528-539 Doi: 10.1158/1535-7163.MCT-13-0646 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Schwarzenberg, J; Czernin, J; Cloughesy, TF; Ellingson, BM; Pope, WB; Grogan, T; Elashoff, D; Geist, C; Silverman, DH; Phelps, ME; Chen, W Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
Clin Cancer Res. 2014; 20(13):3550-3559 Doi: 10.1158/1078-0432.CCR-13-1440 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Wackernagel, W; Holl, E; Tarmann, L; Mayer, C; Avian, A; Schneider, M; Kapp, KS; Langmann, G Local tumour control and eye preservation after gamma-knife radiosurgery of choroidal melanomas.
Br J Ophthalmol. 2014; 98(2):218-223 Doi: 10.1136/bjophthalmol-2013-304031
Web of Science PubMed FullText FullText_MUG



Belev, B; Brčić, I; Prejac, J; Golubić, ZA; Vrbanec, D; Božikov, J; Alerić, I; Boban, M; Razumović, JJ Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
World J Gastroenterol. 2013; 19(4): 523-527. Doi: 10.3748/wjg.v19.i4.523 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Brookman-May, S; May, M; Shariat, SF; Xylinas, E; Stief, C; Zigeuner, R; Chromecki, T; Burger, M; Wieland, WF; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Feciche, B; Truss, M; Gilfrich, C; Pahernik, S; Hohenfellner, M; Zastrow, S; Wirth, MP; Novara, G; Carini, M; Minervini, A; Simeone, C; Antonelli, A; Mirone, V; Longo, N; Simonato, A; Carmignani, G; Ficarra, V; Members of the CORONA project and the SATURN project Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Eur Urol. 2013; 64(3):472-477 Doi: 10.1016/j.eururo.2012.06.030
Web of Science PubMed FullText FullText_MUG


Fajkovic, H; Cha, EK; Jeldres, C; Robinson, BD; Rink, M; Xylinas, E; Chromecki, TF; Breinl, E; Svatek, RS; Donner, G; Tagawa, ST; Tilki, D; Bastian, PJ; Karakiewicz, PI; Volkmer, BG; Novara, G; Joual, A; Faison, T; Sonpavde, G; Daneshmand, S; Lotan, Y; Scherr, DS; Shariat, SF Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Eur Urol. 2013; 64(5):837-845 Doi: 10.1016/j.eururo.2012.07.026
Web of Science PubMed FullText FullText_MUG


Rieken, M; Kluth, LA; Xylinas, E; Seitz, C; Fajkovic, H; Karakiewicz, PI; Lotan, Y; Briganti, A; Loidl, W; Faison, T; Crivelli, JJ; Scherr, DS; Bachmann, A; Tewari, AK; Kautzky-Willer, A; Pummer, K; Shariat, SF Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy.
Prostate Cancer Prostatic Dis. 2013; 16(4):367-371 Doi: 10.1038/pcan.2013.31 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Youssef, RF; Shariat, SF; Lotan, Y; Cost, N; Wood, CG; Sagalowsky, AI; Zigeuner, R; Langner, C; Chromecki, TF; Montorsi, F; Bolenz, C; Margulis, V Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
Urol Oncol. 2013; 31(5):676-681 Doi: 10.1016/j.urolonc.2011.05.006
Web of Science PubMed FullText FullText_MUG



Cha, EK; Shariat, SF; Kormaksson, M; Novara, G; Chromecki, TF; Scherr, DS; Lotan, Y; Raman, JD; Kassouf, W; Zigeuner, R; Remzi, M; Bensalah, K; Weizer, A; Kikuchi, E; Bolenz, C; Roscigno, M; Koppie, TM; Ng, CK; Fritsche, HM; Matsumoto, K; Walton, TJ; Ehdaie, B; Tritschler, S; Fajkovic, H; Martinez-Salamanca, JI; Pycha, A; Langner, C; Ficarra, V; Patard, JJ; Montorsi, F; Wood, CG; Karakiewicz, PI; Margulis, V Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Eur Urol. 2012; 61(4):818-825 Doi: 10.1016/j.eururo.2012.01.021
Web of Science PubMed FullText FullText_MUG


Chromecki, TF; Cha, EK; Pummer, K; Scherr, DS; Tewari, AK; Sun, M; Fajkovic, H; Roehrborn, CG; Ashfaq, R; Karakiewicz, PI; Shariat, SF Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
BJU Int. 2012; 110(1):63-68 Doi: 10.1111/j.1464-410X.2011.10703.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Chromecki, TF; Mauermann, J; Cha, EK; Svatek, RS; Fajkovic, H; Karakiewicz, PI; Lotan, Y; Tilki, D; Bastian, PJ; Volkmer, BG; Montorsi, F; Kassouf, W; Novara, G; Fritsche, HM; Ficarra, V; Stief, CG; Dinney, CP; Skinner, E; Pummer, K; Fradet, Y; Shariat, SF Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy.
World J Urol. 2012; 30(6):753-759 Doi: 10.1007/s00345-011-0772-2
Web of Science PubMed FullText FullText_MUG


Fajkovic, H; Cha, EK; Jeldres, C; Donner, G; Chromecki, TF; Margulis, V; Novara, G; Lotan, Y; Raman, JD; Kassouf, W; Seitz, C; Bensalah, K; Weizer, A; Kikuchi, E; Roscigno, M; Remzi, M; Matsumoto, K; Breinl, E; Pycha, A; Ficarra, V; Montorsi, F; Karakiewicz, PI; Scherr, DS; Shariat, SF Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
J Urol. 2012; 187(3): 845-851. Doi: 10.1016/j.juro.2011.10.158
Web of Science PubMed FullText FullText_MUG


Froehlich, EV; Scheipl, S; Lazary, A; Varga, PP; Schmid, C; Stammberger, H; Beham, A; Bodo, K; Schroettner, H; Quehenberger, F; Windhager, R; Liegl, B; Leithner, A Expression of Ezrin, MMP-9, and COX-2 in 50 Chordoma Specimens: A Clinical and Immunohistochemical Analysis.
Spine (Phila Pa 1976). 2012; 37(13):E757-E767 Doi: 10.1097/BRS.0b013e31824782e1
Web of Science PubMed FullText FullText_MUG


Lax, S; Schauer, G; Prein, K; Kapitan, M; Silbert, D; Berghold, A; Berger, A; Trauner, M Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis.
Int J Cancer. 2012; 130(10): 2232-2239. Doi: 10.1002/ijc.26293 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Marszalek, M; Carini, M; Chlosta, P; Jeschke, K; Kirkali, Z; Knüchel, R; Madersbacher, S; Patard, JJ; Van Poppel, H Positive surgical margins after nephron-sparing surgery.
Eur Urol. 2012; 61(4):757-763 Doi: 10.1016/j.eururo.2011.11.028
Web of Science PubMed FullText FullText_MUG


Scheipl, S; Froehlich, EV; Leithner, A; Beham, A; Quehenberger, F; Mokry, M; Stammberger, H; Varga, PP; Lazary, A; Windhager, R; Gattenloehner, S; Liegl, B Does insulin-like growth factor 1 receptor (IGF-1R) targeting provide new treatment options for chordomas? A retrospective clinical and immunohistochemical study.
Histopathology. 2012; 60(6):999-1003 Doi: 10.1111/j.1365-2559.2012.04186.x
Web of Science PubMed FullText FullText_MUG


Stupp, R; Wong, ET; Kanner, AA; Steinberg, D; Engelhard, H; Heidecke, V; Kirson, ED; Taillibert, S; Liebermann, F; Dbaly, V; Ram, Z; Villano, JL; Rainov, N; Weinberg, U; Schiff, D; Kunschner, L; Raizer, J; Honnorat, J; Sloan, A; Malkin, M; Landolfi, JC; Payer, F; Mehdorn, M; Weil, RJ; Pannullo, SC; Westphal, M; Smrcka, M; Chin, L; Kostron, H; Hofer, S; Bruce, J; Cosgrove, R; Paleologous, N; Palti, Y; Gutin, PH NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Eur J Cancer. 2012; 48(14):2192-2202 Doi: 10.1016/j.ejca.2012.04.011 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Welter, S; Grabellus, F; Bauer, S; Schuler, M; Eberhardt, W; Tötsch, M; Stamatis, G Growth patterns of lung metastases from sarcoma: prognostic and surgical implications from histology.
Interact Cardiovasc Thorac Surg. 2012; 15(4): 612-617. Doi: 10.1093/icvts/ivs269 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



Mrak, K; Jagoditsch, M; Leibl, S; Klingler, A; Tschmelitsch, J Influence of pT3 subgroups on outcome of R0-resected colorectal tumors.
SOUTH MED J. 2011; 104(11): 722-730. Doi: 10.1097/SMJ.0b013e3182321271
Web of Science PubMed FullText FullText_MUG


Mueller, AA; Paysan, P; Schumacher, R; Zeilhofer, HF; Berg-Boerner, BI; Maurer, J; Vetter, T; Schkommodau, E; Juergens, P; Schwenzer-Zimmerer, K Missing facial parts computed by a morphable model and transferred directly to a polyamide laser-sintered prosthesis: an innovation study.
Br J Oral Maxillofac Surg. 2011; 49(8): e67-e71. Doi: 10.1016/j.bjoms.2011.02.007
Web of Science PubMed FullText FullText_MUG


Shariat, SF; Savage, C; Chromecki, TF; Sun, M; Scherr, DS; Lee, RK; Lughezzani, G; Remzi, M; Marberger, MJ; Karakiewicz, PI; Vickers, AJ Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.
CANCER-AM CANCER SOC. 2011; 117(13): 2892-2897. Doi: 10.1002/cncr.25903 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



Issels, RD; Lindner, LH; Verweij, J; Wust, P; Reichardt, P; Schem, BC; Abdel-Rahman, S; Daugaard, S; Salat, C; Wendtner, CM; Vujaskovic, Z; Wessalowski, R; Jauch, KW; Dürr, HR; Ploner, F; Baur-Melnyk, A; Mansmann, U; Hiddemann, W; Blay, JY; Hohenberger, P; for the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG); the European Society for Hyperthermic Oncology (ESHO) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Lancet Oncol. 2010; 11(6): 561-570. Doi: 10.1016/S1470-2045(10)70071-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Zigeuner, R; Shariat, SF; Margulis, V; Karakiewicz, PI; Roscigno, M; Weizer, A; Kikuchi, E; Remzi, M; Raman, JD; Bolenz, C; Bensalah, K; Capitanio, U; Koppie, TM; Kassouf, W; Sircar, K; Patard, JJ; Fernández, MI; Wood, CG; Montorsi, F; Ströbel, P; Wheat, JC; Haitel, A; Oya, M; Guo, CC; Ng, C; Chade, DC; Sagalowsky, A; Langner, C Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
Eur Urol. 2010; 57(4):575-581 Doi: 10.1016/j.eururo.2009.11.035
Web of Science PubMed FullText FullText_MUG Google Scholar



Gonzalez-Angulo, AM; Litton, JK; Broglio, KR; Meric-Bernstam, F; Rakkhit, R; Cardoso, F; Peintinger, F; Hanrahan, EO; Sahin, A; Guray, M; Larsimont, D; Feoli, F; Stranzl, H; Buchholz, TA; Valero, V; Theriault, R; Piccart-Gebhart, M; Ravdin, PM; Berry, DA; Hortobagyi, GN High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.
J Clin Oncol. 2009; 27(34):5700-5706 Doi: 10.1200/JCO.2009.23.2025 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Hoff, KV; Hinkes, B; Gerber, NU; Deinlein, F; Mittler, U; Urban, C; Benesch, M; Warmuth-Metz, M; Soerensen, N; Zwiener, I; Goette, H; Schlegel, PG; Pietsch, T; Kortmann, RD; Kuehl, J; Rutkowski, S Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91.
Eur J Cancer. 2009; 45(7): 1209-1217. Doi: 10.1016/j.ejca.2009.01.015
Web of Science PubMed FullText FullText_MUG Google Scholar


Jost, G; Zimmerer, S; Frank, S; Cordier, D; Merlo, A Intradural spinal metastasis of renal cell cancer. Report of a case and review of 26 published cases.
Acta Neurochir (Wien). 2009; 151(7): 815-821. Doi: 10.1007/s00701-009-0358-6 (- Case Report)
Web of Science PubMed FullText FullText_MUG


Margulis, V; Shariat, SF; Matin, SF; Kamat, AM; Zigeuner, R; Kikuchi, E; Lotan, Y; Weizer, A; Raman, JD; Wood, CG; Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma Collaboration Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Cancer. 2009; 115(6): 1224-1233. Doi: 10.1002/cncr.24135 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar



Gold, JS; Are, C; Kornprat, P; Jarnagin, WR; Gönen, M; Fong, Y; DeMatteo, RP; Blumgart, LH; D'Angelica, M Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients.
Ann Surg. 2008; 247(1):109-117 Doi: 10.1097/SLA.0b013e3181557e47
Web of Science PubMed FullText FullText_MUG


Kaddu, S; Wolf, I; Horn, M; Kerl, H Epithelioid sarcoma with angiomatoid features: report of an unusual case arising in an elderly patient within a burn scar.
J Cutan Pathol. 2008; 35(3):324-328 Doi: 10.1111/j.1600-0560.2007.00802.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar


Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum